Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Colin Weekes

GI Oncology · MGH

View

Dr. Elizabeth Jaffee

GI Oncology · Johns Hopkins

View

Dr. Aparna Parikh

GI Oncology · PHS

View

Dr. Laura Vater

GI Oncology · IUSM

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    HSDr. Harshabad Singh

    Dr. Harshabad Singh

    Medical Oncology · Gastrointestinal Oncology
    Massachusetts General Hospital
    harshabad

    Research

    The Impact of Multi-Omic Data Incorporation in Precision Oncology

    Via Multiple journals (various publications)

    Research

    A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

    2025

    Via Cancer Immunology Research

    Research

    Crypt density and recruited enhancers underlie intestinal tumour initiation

    2025

    Via Nature

    Research

    Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma

    2025

    Via Clinical Cancer Research

    Research

    Biliary tract neoplasms from common to rare: diagnosis, assessment, and management

    2025

    Via Abdominal Radiology

    Research

    Eculizumab Prophylaxis for Systematic Rechallenging Gemcitabine in Gemcitabine-Induced Thrombotic Microangiopathy: A Case Report

    2025

    Via American Journal of Kidney Diseases

    Research

    Integrative genomic identification of therapeutic targets for pancreatic cancer

    2025

    Via Cell Reports

    Research

    Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer

    2025

    Via JCO Precision Oncology

    Research

    PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer

    2025

    Via Journal of Clinical Oncology

    Research

    Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting

    2024

    Via NPJ Precision Oncology

    Research

    Bridging the Divide: From Universal Germline Testing Guidance to Real-World Implementation in Pancreatic Cancer Care

    2024

    Via JCO Oncology Practice

    Research

    Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

    2024

    Via Cancer Immunology Research

    Research

    Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

    2024

    Via Nature Communications

    Research

    Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer

    2024

    Via Clinical Cancer Research

    Research

    Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-Refractory G12C-Mutated Colorectal Cancer: A Case Report

    2024

    Via JCO Precision Oncology